[go: up one dir, main page]

BRPI0411145A - combinações antiartrìticas - Google Patents

combinações antiartrìticas

Info

Publication number
BRPI0411145A
BRPI0411145A BRPI0411145-1A BRPI0411145A BRPI0411145A BR PI0411145 A BRPI0411145 A BR PI0411145A BR PI0411145 A BRPI0411145 A BR PI0411145A BR PI0411145 A BRPI0411145 A BR PI0411145A
Authority
BR
Brazil
Prior art keywords
combinations
antiarthritic
erî2
antiartritic
treating
Prior art date
Application number
BRPI0411145-1A
Other languages
English (en)
Inventor
Heather Anne Harris
Damien P Quinn
Regina H Kurrasch
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0411145A publication Critical patent/BRPI0411145A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMBINAçõES ANTIARTRìTICAS". Esta invenção fornece combinações de um ligador seletivo de ER<225> com um agente antiartrite que são úteis no tratamento ou na inibição da artrite.
BRPI0411145-1A 2003-05-21 2004-05-20 combinações antiartrìticas BRPI0411145A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47238203P 2003-05-21 2003-05-21
PCT/US2004/016030 WO2004103365A1 (en) 2003-05-21 2004-05-20 Antiarthritic combinations

Publications (1)

Publication Number Publication Date
BRPI0411145A true BRPI0411145A (pt) 2006-07-11

Family

ID=33476949

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411145-1A BRPI0411145A (pt) 2003-05-21 2004-05-20 combinações antiartrìticas

Country Status (17)

Country Link
US (1) US20040248865A1 (pt)
EP (1) EP1631283A1 (pt)
JP (1) JP2007500223A (pt)
KR (1) KR20060013666A (pt)
CN (1) CN1791404A (pt)
AR (1) AR044428A1 (pt)
AU (1) AU2004240668A1 (pt)
BR (1) BRPI0411145A (pt)
CA (1) CA2524116A1 (pt)
CL (1) CL2004001186A1 (pt)
EC (1) ECSP056177A (pt)
MX (1) MXPA05012562A (pt)
NO (1) NO20056070L (pt)
RU (1) RU2005140041A (pt)
TW (1) TW200500065A (pt)
WO (1) WO2004103365A1 (pt)
ZA (1) ZA200509376B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005311833A1 (en) * 2004-12-02 2006-06-08 Wyeth Formulations of substituted benzoxazoles
US20060210644A1 (en) * 2004-12-16 2006-09-21 Bruce Levin Materials, methods, and devices for treatment of arthropathies and spondylopathies
WO2006104172A1 (ja) * 2005-03-29 2006-10-05 Kowa Co., Ltd. 関節リウマチの予防及び／又は治療薬
PE20071043A1 (es) * 2006-02-14 2007-10-23 Wyeth Corp FORMULACIONES FARMACEUTICAS ACUOSAS QUE COMPRENDE LIGANDOS SELECTIVOS DEL RECEPTOR DE ESTROGENO ERß
RU2367430C1 (ru) * 2008-04-16 2009-09-20 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ прогноза эффективности лечения ревматоидного артрита симвастатином
BRPI0910735A2 (pt) * 2008-04-22 2019-09-24 Toyama Chemical Co Ltd uso de um derivado de benzofenona e de um ou mais agentes imunossupressores em combinação, composição farmacéutica para o tratamento de doenças autoimunes, e, kit
CN104825487A (zh) * 2009-05-18 2015-08-12 香港大学 治疗炎症性关节炎的组合物和方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
MXPA01002173A (es) * 1998-08-28 2003-07-14 Scios Inc Inhibidores de p38-alfa cinasa.
US6080580A (en) * 1998-10-05 2000-06-27 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
US6225311B1 (en) * 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6541477B2 (en) * 1999-08-27 2003-04-01 Scios, Inc. Inhibitors of p38-a kinase
EP1341768A1 (en) * 2000-12-07 2003-09-10 AstraZeneca AB Therapeutic benzimidazole compounds
US6589980B2 (en) * 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
TWI306450B (en) * 2001-12-13 2009-02-21 Wyeth Corp Substituted phenyl naphthalenes as estrogenic agents

Also Published As

Publication number Publication date
CL2004001186A1 (es) 2005-04-15
ZA200509376B (en) 2007-04-25
RU2005140041A (ru) 2006-05-10
JP2007500223A (ja) 2007-01-11
CN1791404A (zh) 2006-06-21
US20040248865A1 (en) 2004-12-09
AR044428A1 (es) 2005-09-14
CA2524116A1 (en) 2004-12-02
KR20060013666A (ko) 2006-02-13
TW200500065A (en) 2005-01-01
AU2004240668A1 (en) 2004-12-02
ECSP056177A (es) 2006-04-19
MXPA05012562A (es) 2006-04-18
NO20056070L (no) 2006-02-14
EP1631283A1 (en) 2006-03-08
WO2004103365A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
ECSP066635A (es) Quinolinas utiles en el tratamiento de enfermedades cardiovasculares
ECSP034874A (es) Benzoilsulfonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales
ES2190246T3 (es) Nuevos compuestos de tiazolopirimidina.
TW200420573A (en) Bifunctional heterocyclic compounds and methods of making and using same
TW200500071A (en) Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
PT1560812E (pt) Compostos de aminociclohexil eter e suas utilizacoes
ES2177316T3 (es) Anticuerpos humanos antifacotores ix/ixa.
DE60312211D1 (de) Haarbehandlungsmittel
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
BRPI0411145A (pt) combinações antiartrìticas
AU2003294253A8 (en) Emulsions including surface-modified organic molecules
BRPI0617788A2 (pt) processos isolados estaticamente verificáveis com comunicação interprocessos
WO2005085849A3 (en) Biohazard identification by fluorescent immunoassay and single molecule detection
DE60039999D1 (de) Bindungsoberfläche
GT199800081A (es) Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para el tratamiento delcancer.
BR0014626A (pt) Análise de leptina
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
ES2166219T3 (es) Empleo de mezclas detergentes como solubilizantes.
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
WO2004050834A3 (en) GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER
EP1436279A4 (en) CHEMICAL COMPOUNDS
PT1585711E (pt) Composicoes fertilizantes soluveis que compreendem fosfatos de calcio e/ou de magnesio
WO2002094976A3 (en) Identification of antimicrobial agents
ES2184608B1 (es) Fertilizantes organicos-minerales complejos.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.